| Attributes | Values |
|---|
| rdf:type
| |
| description
| - artículu científicu espublizáu en 1989 (ast)
- vědecký článek publikovaný v roce 1989 (cs)
- article scientifique publié en 1989 (fr)
- наукова стаття, опублікована в серпні 1989 (uk)
- 1989 թվականի օգոստոսին հրատարակված գիտական հոդված (hy)
- 1989 թուականի Օգոստոսին հրատարակուած գիտական յօդուած (hyw)
- vedecký článok (publikovaný 1989/08/25) (sk)
- مقالة علمية (نشرت في 25-8-1989) (ar)
- scientific journal article (en)
- im August 1989 veröffentlichter wissenschaftlicher Artikel (de)
- wetenschappelijk artikel (gepubliceerd op 1989/08/25) (nl)
|
| publication date
| |
| publication date
| |
| language of work or name
| |
| language of work or name
| |
| author name string
| |
| OpenCitations bibliographic resource ID
| |
| OpenCitations bibliographic resource ID
| |
| author name string
| - B. Rossi
- P. Auberger
- A. Le Cam
- G. Le Cam
- G. Pages
- J. O. Contreres
- L. Falquerho
|
| OpenCitations bibliographic resource ID
| |
| rdfs:label
| - Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity (en)
- Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity (nl)
- Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity (ast)
|
| skos:prefLabel
| - Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity (en)
- Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity (nl)
- Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity (ast)
|
| name
| - Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity (en)
- Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity (nl)
- Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity (ast)
|
| title
| |
| title
| - Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.1016/0092-8674(89)90098-6
|
| is about
of | |
| is cites work
of | - Obesity and renal disease: not all fat is created equal and not all obesity is harmful to the kidneys
- The nucleotide and deduced amino acid structures of sheep and pig fetuin. Common structural features of the mammalian fetuin family.
- Insulin resistance in patients with chronic kidney disease
- alpha2-Heremans-Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action
- Lifestyle intervention in individuals with normal versus impaired glucose tolerance
- Involvement of phosphatidylinositol 3-kinase, but not RalGDS, in TC21/R-Ras2-mediated transformation
- Allelic Imbalance of mRNA Associated with α2-HS Glycoprotein (Fetuin-A) Polymorphism
- Genetically elevated fetuin-A levels, fasting glucose levels, and risk of type 2 diabetes: the cardiovascular health study
- Association of alpha2-HS glycoprotein (AHSG, fetuin-A) polymorphism with AHSG and phosphate serum levels
- Sevelamer and the bone-vascular axis in chronic kidney disease: bone turnover, inflammation, and calcification regulation
- The insulin receptor--a critical link in glucose homeostasis and insulin action
- Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-induced obesity.
- Association of serum fetuin-A with carotid arterial stiffness.
- Bovine fetuin is an inhibitor of insulin receptor tyrosine kinase
- Modification of macrophage response to lipopolysaccharide by fetuin
- Betaine homocysteine methyltransferase: gene cloning and expression analysis in rat liver cirrhosis
- Immuno-gold electron microscopical detection of heat shock protein 60 (hsp60) in mitochondria of rat hepatocytes and myocardiocytes
- Gender differences in rat plasma proteome in response to high-fat diet.
- Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study
- Metabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and Hepatokines
- Fetuin-A induces cytokine expression and suppresses adiponectin production
- Fetuin--an old friend revisited
- Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK.
- Fetuin-A and incident diabetes mellitus in older persons
- The role of hepatokines in metabolism
- NF-kappaB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance
- The nucleotide and partial amino acid sequences of rat fetuin. Identity with the natural tyrosine kinase inhibitor of the rat insulin receptor
- Visceral and subcutaneous adipose tissue express and secrete functional alpha2hsglycoprotein (fetuin a) especially in obesity.
- Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles
- Serum fetuin-A associates with type 2 diabetes and insulin resistance in Chinese adults
- Plasma fetuin-A levels and the risk of type 2 diabetes
- Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene
- Usefulness of fetuin-A to predict risk for cardiovascular disease among patients with obstructive sleep apnea
- Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease
- Sex-specific association of fetuin-A with type 2 diabetes in older community-dwelling adults: the Rancho Bernardo study
- AHSG gene variant is associated with leanness among Swedish men.
- Fetuin-A and change in body composition in older persons
|
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)